关键词：透析；肾移植手术；DN；医疗器械
摘 要：DN is a disease that affects the kidney glomeruli. The disease is caused by high blood sugar or hyperglycemia. When diabetes damages the kidneys, which contain millions of tiny blood vessel clusters (glomeruli) that filter waste from the blood, it results in DN, also called diabetic kidney disease.The Global Diabetic Nephropathy market is expected to witness slow growth during the period 2013-2018. In 2013, the market was dominated by the Americas, where the major contribution was from the US, and this trend is expected to continue during the forecast period. The Americas was followed by the EMEA and APAC regions. There is a vast opportunity for vendors in this market to expand into the APAC region. The market is expected to witness an improvement in its growth rate and post a CAGR of 5.19 percent during the forecast period.
目 录：

01. Executive Summary

02. List of Abbreviations

03. Scope of the Report

03.1 Market Overview

03.2 Product Offerings

Product Profiles

04. Market Research Methodology

04.1 Market Research Process

04.2 Research Methodology

05. Introduction

06. Market Landscape

06.1 Market Overview

06.2 Market Size and Forecast

06.3 Diabetic Nephropathy Market in the US

06.3.1 Market Size and Forecast

06.4 Diabetic Nephropathy Market in Europe

06.4.1 Market Size and Forecast

06.5 Five Forces Analysis

07. Late-stage Pipeline Snapshot

08. Rate of Incidence and Prevalence

09. Geographical Segmentation

09.1 Diabetic Nephropathy Market in the Americas

09.1.1 Market Size and Forecast

09.2 Diabetic Nephropathy Market in the EMEA

Region

09.2.1 Market Size and Forecast

09.3 Diabetic Nephropathy Market in the APAC

Region

09.3.1 Market Size and Forecast

10. Buying Criteria

11. Market Growth Drivers

12. Drivers and their Impact

13. High - Very high impact, with radical

influence on the growth of the market

Market Challenges

14. Impact of Drivers and Challenges

15. Market Trends

16. Trends and their Impact

17. Vendor Landscape

17.1 Competitive Scenario

17.1.1 Key News

17.1.2 Mergers and Acquisitions

17.2 Market Share Analysis 2013

17.3 Other Prominent Vendors

18. Key Vendor Analysis

18.1 Merck & Co. Inc.

18.1.1 Business Overview

18.1.2 Business Segmentation

18.1.3 Key Information

18.1.4 SWOT Analysis

18.2 Mitsubishi Tanabe Pharma Corp.

18.2.1 Business Overview

18.2.2 Key Information

18.2.3 SWOT Analysis

18.3 Novartis AG

18.3.1 Business Overview

18.3.2 Business Segmentation

18.3.3 Key Information

18.3.4 SWOT Analysis

18.4 Sanofi S.A.

18.4.1 Business Overview

18.4.2 Business Segmentation

18.4.3 Key Information

18.4.4 SWOT Analysis

19. Other Reports in this Series